Palantir ($PLTR) Quick Update: Support Reaction Validated

139
Palantir (PLTR) Quick Update: Support Reaction Validated – 3-Part Take-Profit Execution Blueprint
### 💻 Palantir Technologies (PLTR) Update (Ref: PLTR_2026-06-16_12-03-44.png)

Following up on yesterday's structural study, Palantir (PLTR - NASDAQ) has reacted exactly as anticipated. The market printed an interesting bullish candle right off the major support zone, currently trading up **+5.25% at 134.71** and defending the **72-period EMA (red line at 134.01)**.

With the mean-reversion reversal trigger officially active, here is our streamlined, 3-part tactical execution blueprint:

---

### 🛡️ Risk & Trade Management Protocol:
* **The Stop Loss:** Securely anchored right below the key horizontal structural support line of **126.29**.
* **The Capital Protection Trigger:** As soon as price action hits the **1:1 Risk/Reward (1RR)** milestone, the protective Stop Loss for the remainder of the position will be trailed directly to the **original entry price (Break-Even)**, eliminating all downside risk.

### 🎯 The 3-Part Scaling-Out Strategy (Take-Profit):
To maximize probability and lock in consistent equity growth, we are taking a structured scaling approach:
1. **Target 1 (1:1 Risk/Reward):** Take profit on **1/3 of the total position** to secure initial gains.
2. **Target 2 (1.5:1 Risk/Reward):** Take profit on the second **1/3 of the position** (**2/3 total scaled out**) as momentum expands.
3. **Target 3 (2:1 Risk/Reward):** Fully close out the remaining runner at the master target node.

### Summary:
The buyers showed up right on cue. We now let the mathematical edge of our 3-part exit matrix handle the expansion while maintaining absolute discipline on our risk floor.

---
📊 **ChartPro Data**
*Systematic Technical Research & Position Engineering.*

⚠️ **Disclaimer:** For educational and informational purposes only. This update represents a personal trading framework and does not constitute financial or investment advice.

Declinazione di responsabilità

Le informazioni e le pubblicazioni non sono intese come, e non costituiscono, consulenza o raccomandazioni finanziarie, di investimento, di trading o di altro tipo fornite o approvate da TradingView. Per ulteriori informazioni, consultare i Termini di utilizzo.